| Literature DB >> 29396171 |
Michela Stagnaro1, Livia Pisciotta1, Marcella Gherzi1, Maja Di Rocco2, Fiorella Gurrieri3, Elena Parrini4, Giulia Prato1, Edvige Veneselli1, Elisa De Grandis5.
Abstract
Mutations in the ATP1A3 gene, which encodes the alpha3-subunit of sodium-potassium ATPase, are related to a spectrum of neurological diseases including Rapid onset Dystonia-Parkinsonism (RDP), Alternating Hemiplegia of Childhood (AHC) and Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy and Sensorineural hearing loss (CAPOS) syndrome. Moreover, an increasing number of patients with intermediate and non classical phenotypes have been reported. Herein we describe 7 patients with 6 different de novo ATP1A3 mutations, and we focus on paroxysmal and chronic movement disorders with the help of video documentation. Our cases confirm that ATP1A3-related neurological disorders make up a phenotypic continuum rather than overlapping syndromes, in which early onset dystonia, ataxia and paroxysmal episodes with triggering or worsening factors are key diagnostic clues. Moreover, our experience suggests that ATP1A3 gene analysis should be extended both to children with channelopathy-like spells and to patients with early onset, fever-related encephalopathy.Entities:
Keywords: ATP1A3; Dystonia; Genotype; Paroxysmal; Phenotype; Triggers
Mesh:
Substances:
Year: 2018 PMID: 29396171 DOI: 10.1016/j.ejpn.2018.01.010
Source DB: PubMed Journal: Eur J Paediatr Neurol ISSN: 1090-3798 Impact factor: 3.140